Funded by an Office of Naval Research grant worth nearly $800,000, Gollamudi and her lab group are developing a novel ...

As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

A recent study reveals that people who are highly open to new experiences tend to have fewer children. Scientists attribute this to delayed parenthood, shorter romantic relationships, and a lower ...

Across much of modern health research, children are measured—but not always heard. For much of the past half-century, health ...

FDA's Plausible Mechanism Framework streamlines individualized therapy approvals for ultra-rare diseases.

Inida is rich in catalysis discovery, but poor in translating its knowledge into technologies. Here's how that can change.

The automatic detection of surface-level irregularities—defects or anomalies—in 3D data is of significant interest for various real-world purposes, such as industrial quality inspection, ...

Expanding across state lines signals growth, opportunity, and operational maturity. However, for business owners and human ...

Artificial intelligence is a structural force reshaping capital flows, business models, and the very frameworks investors use ...

In the wake of the germline editing controversy, when Chinese scientist He Jianku illegally edited the embryos of human twins ...

For too long, the promise of personalized therapies has been tantalizingly close, yet frustratingly out of reach for ...

By Dr. Michael Kwabla ADAFLAGBE In today’s interconnected business world, both multinational corporations and local Ghanaian ...